A recent proteomic analysis of platelets indicated that agonist–induced phosphatidylserine exposure and integrin αIIbβ3 activation were impaired in COVID-19 patients, and that COVID-19 led to maximal levels of P selectin–dependent platelet–neutrophil aggregates [68]. The gene discussed is SELP; the disease is COVID-19.